Add BrightSurf on Google Email

AI can speed design of health software

A new study finds that generative AI can accelerate the design of healthcare software, particularly for complex medical problems like diabetes prevention. Researchers at NYU Langone Health used ChatGPT to develop a personalized automatic messaging system in over 40 hours, compared to 200 programmer hours with non-AI enabled efforts.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of Medical Internet Research·TypeCase study·DateMar 6, 2024

Weight loss and diabetes management drug linked to increased residual gastric content before anesthesia

A study published in JAMA Surgery found that 56% of patients using GLP-1 RAs had significant gastric contents on ultrasound before elective procedures, despite adequate fasting. The study suggests that conventional fasting times may need to be reexamined for this patient subset.

SourceUniversity of Texas Health Science Center at Houston·JournalJAMA Surgery·TypeObservational study·DateMar 6, 2024

How does a diabetes drug lessen symptoms of depression?

Research has shown that dulaglutide, a diabetes drug, can reduce depressive-like behaviors in mice. The study identified four major pathways involved and linked markers of depression to lipid metabolism and tryptophan metabolism. This new perspective may facilitate the use of dulaglutide as a potential therapeutic strategy for depression.

SourceWiley·JournalBrain and Behavior·DateMar 6, 2024

Journal of Pharmaceutical Analysis articles provide novel insights into previously unknown disease mechanisms

Researchers decode underlying mechanisms of DCM, hippocampal neurotoxicity, and dysbiosis mediated AD progression using mass spectrometry imaging. The studies found metabolic changes in DCM rat hearts and regulation of CYPs in the hippocampus, providing new perspectives on treatment strategies.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateFeb 26, 2024

A study demonstrates one of the reasons why the Mediterranean diet improves kidney health in patients with diabetes

A study published by the University of Córdoba and Maimonides Institute for Biomedical Research found that a Mediterranean diet reduces levels of harmful compounds called AGEs, which can accumulate in the bodies of diabetic patients with kidney problems. This dietary pattern may mitigate kidney disease deterioration in diabetic patients.

SourceUniversity of Córdoba·JournalDiabetes & Metabolism Journal·DateFeb 20, 2024

Pusan National University researchers reveal how diabetes weakens gum defense

Researchers from Pusan National University discovered a link between diabetes and periodontitis, showing pro-inflammatory cytokines rise in classical monocytes. The study highlights the systemic impact of these conditions on immune regulation and suggests a potential therapeutic target to reduce diabetes risk.

SourcePusan National University·JournalClinical and Translational Medicine·TypeExperimental study·DateFeb 15, 2024

Gargling away the bad bacteria in type 2 diabetes

Researchers from Osaka University found that gargling with an antiseptic mouthwash can reduce periodontitis-related bacteria in patients with type 2 diabetes. This simple method may improve the lives of people with periodontitis-linked diseases such as diabetes, dementia, and cardiovascular disease.

SourceOsaka University·JournalScientific Reports·TypeObservational study·DateFeb 14, 2024

Reducing diabetes medication costs can help improve outcomes, especially for low-income patients

A new study found that reducing out-of-pocket costs for patients with diabetes can lead to improved health outcomes, particularly among those living in lower-income areas. The study showed a 10.2% decrease in preventable diabetes complications among PDL members from lower-income areas compared to the control group.

SourceHarvard Pilgrim Health Care Institute·JournalJAMA Health Forum·DateFeb 9, 2024

Research from the Korea University College of Medicine explores the combined health impact of diabetes and sarcopenia in the elderly

A study from the Korea University College of Medicine reveals that co-occurrence of diabetes and sarcopenia significantly elevates cardiovascular mortality, with nearly doubling the risk of both all-cause and cardiovascular deaths. Implementing preventive measures such as lifestyle changes, exercise, and balanced diet can mitigate this...

SourceKorea University College of Medicine·JournalMetabolism·TypeObservational study·DateJan 23, 2024

No increase in preventable illnesses, deaths in kids during pandemic, but delays in some diagnoses

Despite pandemic disruptions, emergency visits, hospital admissions, and intensive care unit stays were lower for children. However, there were delays in new diagnoses of cancer and diabetes, and an increase in diabetic ketoacidosis among children with diabetes. Researchers urge education campaigns to improve future pandemic preparedness.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateJan 16, 2024

CNIC and the i+12 Institute participate in the most ambitious EU project to reduce the burden of cardiovascular diseases and diabetes

The Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) aims to reduce the burden of cardiovascular diseases and diabetes in EU member states through 143 pilot projects. The project will test and offer solutions throughout the patient journey, focusing on prevention, early detection, treatment, care, and self-management.

Researchers caution diabetes patients’ use of fitness video games

A new study by Staffordshire University warns people with type-1 diabetes to use fitness video games with caution, as they may change perceptions of fatigue levels. The researchers recommend updating measurement tools for virtual game platforms to ensure safe and accurate exercise tracking.

SourceStaffordshire University·JournalJournal of Bodywork and Movement Therapies·TypeRandomized controlled/clinical trial·DateDec 1, 2023

Trend report: High blood pressure increasing in low-income adults; diabetes and obesity on the rise in higher-income adults

A study of over 20,000 middle-aged US adults found lower income status linked to increased hypertension risk. Higher-income adults faced rising rates of diabetes and obesity. Targeted public health initiatives are needed to address growing cardiovascular mortality among middle-aged adults.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateNov 20, 2023

Liver cancer rates increase in each successive generation of Mexican Americans, study finds

A study by the Keck School of Medicine of USC found that liver cancer risk increases with each successive generation of Mexican Americans, particularly among men. The research analyzed data from over 30,000 participants and found third-generation Mexicans to be 66% more likely to develop liver cancer than first-generation individuals.

SourceKeck School of Medicine of USC·JournalCancer·TypeMeta-analysis·DateNov 20, 2023

Semaglutide delivers 20 percent reduction in major adverse cardiovascular events in patients with obesity but no history of diabetes

A 20% reduction in major adverse cardiovascular events has been observed for patients with obesity but no history of diabetes taking semaglutide. This study marks a significant milestone, demonstrating the cardiovascular benefits of semaglutide beyond its weight loss effects.

SourcePennington Biomedical Research Center·JournalNew England Journal of Medicine·DateNov 13, 2023

International clinical trial finds that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity who don’t have diabetes

A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.

SourceCleveland Clinic·JournalNew England Journal of Medicine·DateNov 11, 2023

Understanding the role of GIP in managing diabetes and obesity

Researchers from Helmholtz Munich discovered that GIP decreases body weight by interacting with specific inhibitory neurons in the brain, offering a revolutionary approach to patients worldwide. The study reveals the underlying molecular mechanisms of GIPR:GLP-1R co-agonists and their potential as next-generation anti-obesity drugs.

AGA does not endorse all patients stopping popular diabetes and weight loss drugs prior to endoscopy

The American Gastroenterological Association suggests a balanced approach when treating patients on GLP-1 RAs undergoing endoscopic procedures. AGA recommends proceeding with the procedure as planned for patients who followed standard pre-procedure fasting instructions and do not have symptoms suggesting retained gastric contents.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeSystematic review·DateNov 7, 2023